SCHEMBL564282

SCHEMBL564282

COc1cc(C=O)cc(F)c1O

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.66
STAT3 P40763 2/20 0.66
NFE2L2 Q16236 2/20 0.66
NFKB1 P19838 1/20 0.66
NFKB2 Q00653 1/20 0.66
RELA Q04206 1/20 0.66
PTGS1 P23219 2/20 0.62
PTGES O14684 1/20 0.62
ALDH1A1 P00352 3/20 0.53
TRIM24 O15164 1/20 0.53
HPGD P15428 1/20 0.53
ALDH5A1 P51649 1/20 0.53
ABAT P80404 1/20 0.53
TDP1 Q9NUW8 1/20 0.53
TRIM33 Q9UPN9 1/20 0.53
ERN1 O75460 8/20 0.50
AOX1 Q06278 1/20 0.49
TSHR P16473 1/20 0.48
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31574220 0.86 ALDH1A1 (0.63) ALOX5STAT3NFE2L2NFKB1NFKB2
SCHEMBL1001955 0.86 ALDH1A1 (0.63) ALOX5STAT3NFE2L2NFKB1NFKB2
Syringaldehyde SCHEMBL150376 0.86 ALDH1A1 (0.62) PTGS1ALDH1A1TRIM24HPGDALDH5A1
Syringaldehyde SCHEMBL2110596 0.86 ALDH1A1 (0.62) PTGS1ALDH1A1TRIM24HPGDALDH5A1
Syringaldehyde SCHEMBL30119623 0.86 ALDH1A1 (0.62) PTGS1ALDH1A1TRIM24HPGDALDH5A1
Syringaldehyde SCHEMBL28642631 0.84 ALDH1A1 (0.60) PTGS1ALDH1A1TRIM24HPGDALDH5A1
Syringaldehyde SCHEMBL11013780 0.84 ALDH1A1 (0.60) PTGS1ALDH1A1TRIM24HPGDALDH5A1
Syringaldehyde SCHEMBL28299840 0.84 ALDH1A1 (0.60) PTGS1ALDH1A1TRIM24HPGDALDH5A1
Syringaldehyde SCHEMBL29724072 0.84 ALDH1A1 (0.60) PTGS1ALDH1A1TRIM24HPGDALDH5A1
Syringaldehyde SCHEMBL27352107 0.84 ALDH1A1 (0.60) PTGS1ALDH1A1TRIM24HPGDALDH5A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 396 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025245367-A1 INHIBITING CATECHOL-O-METHYLTRANSFERASE (COMT) PSY THERAPEUTICS, INC. (US) 2025-11-27 WO disclosed
WO-2025227032-A1 METHODS FOR DEGRADATION OF CYCLIN K AND INHIBITION OF CYCLIN DEPENDENT KINASES REMIX THERAPEUTICS INC. (US) 2025-10-30 WO disclosed
EP-3953342-B1 IMPROVED INHIBITORS OF THE NOTCH TRANSCRIPTIONAL ACTIVATION COMPLEX AND METHODS FOR USE OF THE SAME UNIV MIAMI (US) 2025-09-24 EP disclosed
US-RE50453-E1 Indole derivatives as CFTR modulators VERTEX PHARMACEUTICALS INCORPORATED (US) 2025-06-10 US disclosed
US-12275725-B2 Inhibitors of the notch transcriptional activation complex and methods for use of the same UNIVERSITY OF MIAMI (US) 2025-04-15 US disclosed
CN-119390668-A Compound with ketoxime ether structure and application thereof 复旦大学 2025-02-07 CN disclosed
US-20250011285-A1 CYP11A1 INHIBITORS ORION CORPORATION (FI) 2025-01-09 US disclosed
US-20240270762-A1 PENICILLIN-BINDING PROTEIN INHIBITORS SPRING MILL PHARMA, INC. 2024-08-15 US disclosed
EP-4347607-A1 PENICILLIN-BINDING PROTEIN INHIBITORS Venatorx Pharmaceuticals, Inc. (US) 2024-04-10 EP disclosed
US-20240092766-A1 MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS VERTEX PHARMA (US) 2024-03-21 US disclosed
US-5763617-A Cephalosporins ROUSSEL UCLAF (FR) 1998-06-09 US disclosed
US-5728828-A A 3-(3-CHLORO- OR IODOPROP-1-EN-1-YL),7-(2-AMINOTHIAZOL-4-YL) ((CARBOXY)(PHENYL)METHOXYIMINO)ACETAMIDO-3-CEPHEM; GRAMNEGATIVE AND -POSITIVE BACTERIA, ESP. ANTIBIOTIC-RESISTANCE STAPHYLOCOCCUS ROUSSEL UCLAF (FR) 1998-03-17 US disclosed
US-5712266-A Cephalosporins ROUSSEL UCLAF (FR) 1998-01-27 US disclosed
US-5587372-A BACERICIDES ROUSSEL UCLAF (FR) 1996-12-24 US disclosed
EP-0537742-B1 Styrene derivatives MITSUBISHI CHEM CORP (JP) 1996-08-21 EP disclosed
US-5514711-A ANTICARCINOGENIC AGENTS; SIDE EFFECT REDUCTION MITSUBISHI CHEMICAL CORPORATION (JP) 1996-05-07 US disclosed
US-5455238-A Bactericides ROUSSEL UCLAF (FR) 1995-10-03 US disclosed
EP-0551034-A2 Cephalosporins having in position 7 a benzyloxyimino radical substitute, process for their preparation and their use as medicaments ROUSSEL UCLAF (FR) 1993-07-14 EP disclosed
EP-0537742-A2 Styrene derivatives Mitsubishi Chemical Corporation (JP) 1993-04-21 EP disclosed
EP-0400805-A1 Cephalosporin compounds and their use Ishimaru, Toshiyasu (JP) 1990-12-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250011285-A1 CYP11A1 INHIBITORS CYP11B1, CYP19A1, CYP11B2 ALOX5 487/4885STAT3 2877/4885NFE2L2 585/4885
US-12275725-B2 Inhibitors of the notch transcriptional activation complex and methods for use of the same NOTCH1, CBFB, HES1 ALOX5 2293/4885STAT3 55/4885NFE2L2 141/4885
US-20240092766-A1 MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS CFTR, ABCB1, ABCC2 ALOX5 3605/4885STAT3 3618/4885NFE2L2 1086/4885
US-20240270762-A1 PENICILLIN-BINDING PROTEIN INHIBITORS PEPD, BPGM, EBPL ALOX5 4756/4885STAT3 4299/4885NFE2L2 4593/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.